These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 8688357)

  • 1. Normal tissue radiosensitivity--how important is it?
    Burnet NG; Wurm R; Nyman J; Peacock JH
    Clin Oncol (R Coll Radiol); 1996; 8(1):25-34. PubMed ID: 8688357
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The modelled benefits of individualizing radiotherapy patients' dose using cellular radiosensitivity assays with inherent variability.
    Mackay RI; Hendry JH
    Radiother Oncol; 1999 Jan; 50(1):67-75. PubMed ID: 10225559
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Describing patients' normal tissue reactions: concerning the possibility of individualising radiotherapy dose prescriptions based on potential predictive assays of normal tissue radiosensitivity. Steering Committee of the BioMed2 European Union Concerted Action Programme on the Development of Predictive Tests of Normal Tissue Response to Radiation Therapy.
    Burnet NG; Johansen J; Turesson I; Nyman J; Peacock JH
    Int J Cancer; 1998 Dec; 79(6):606-13. PubMed ID: 9842969
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Potential clinical impact of normal-tissue intrinsic radiosensitivity testing.
    Bentzen SM
    Radiother Oncol; 1997 May; 43(2):121-31. PubMed ID: 9192956
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between cellular radiation sensitivity and tissue response may provide the basis for individualising radiotherapy schedules.
    Burnet NG; Nyman J; Turesson I; Wurm R; Yarnold JR; Peacock JH
    Radiother Oncol; 1994 Dec; 33(3):228-38. PubMed ID: 7716263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. How much could the radiotherapy dose be altered for individual patients based on a predictive assay of normal-tissue radiosensitivity?
    Tucker SL; Geara FB; Peters LJ; Brock WA
    Radiother Oncol; 1996 Feb; 38(2):103-13. PubMed ID: 8966222
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Radiation therapy tolerance limits. For one or for all?--Janeway Lecture.
    Peters LJ
    Cancer; 1996 Jun; 77(11):2379-85. PubMed ID: 8635110
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Normal tissue reactions to radiotherapy: towards tailoring treatment dose by genotype.
    Barnett GC; West CM; Dunning AM; Elliott RM; Coles CE; Pharoah PD; Burnet NG
    Nat Rev Cancer; 2009 Feb; 9(2):134-42. PubMed ID: 19148183
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Incorporating Genetic Biomarkers into Predictive Models of Normal Tissue Toxicity.
    Barnett GC; Kerns SL; Noble DJ; Dunning AM; West CM; Burnet NG
    Clin Oncol (R Coll Radiol); 2015 Oct; 27(10):579-87. PubMed ID: 26166774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Interactive determination of the parameters of mathematical models for planning radiotherapy of malignant tumors. I. Mathematical models for calculating dose tolerance, adequate doses and the likelihood of development of radiation complications in normal organs and tissues].
    Klepper LIa
    Med Tekh; 2000; (4):37-41. PubMed ID: 10984881
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Individualization of dose prescription based on normal-tissue dose-volume and radiosensitivity data.
    Sanchez-Nieto B; Nahum AE; Dearnaley DP
    Int J Radiat Oncol Biol Phys; 2001 Feb; 49(2):487-99. PubMed ID: 11173145
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical correlations between late normal tissue endpoints after radiotherapy: implications for predictive assays of radiosensitivity.
    Bentzen SM; Overgaard M; Overgaard J
    Eur J Cancer; 1993; 29A(10):1373-6. PubMed ID: 8398261
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prediction of normal tissue response and individualization of doses in radiotherapy.
    Guirado D; Ruiz de Almodóvar JM
    Phys Med Biol; 2003 Oct; 48(19):3213-23. PubMed ID: 14579861
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Why recent studies relating normal tissue response to individual radiosensitivity might have failed and how new studies should be performed.
    Dikomey E; Borgmann K; Peacock J; Jung H
    Int J Radiat Oncol Biol Phys; 2003 Jul; 56(4):1194-200. PubMed ID: 12829159
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment volume and tissue tolerance.
    Withers HR; Taylor JM; Maciejewski B
    Int J Radiat Oncol Biol Phys; 1988 Apr; 14(4):751-9. PubMed ID: 3350731
    [TBL] [Abstract][Full Text] [Related]  

  • 16. In vitro cellular radiosensitivity in relationship to late normal tissue reactions in breast cancer patients: a multi-endpoint case-control study.
    Vandevoorde C; Depuydt J; Veldeman L; De Neve W; Sebastià N; Wieme G; Baert A; De Langhe S; Philippé J; Thierens H; Vral A
    Int J Radiat Biol; 2016 Dec; 92(12):823-836. PubMed ID: 27586010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Predictive assays for responses of tumors and normal tissues in radiation oncology].
    Riou O; Bourgier C; Brengues M; Bonnefoi N; Michaud HA; Castan F; Gourgou S; Draghici R; Farcy-Jacquet MP; Bons F; Fenoglietto P; Ozsahin M; Azria D
    Cancer Radiother; 2019 Oct; 23(6-7):666-673. PubMed ID: 31451357
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Use of Veff and iso-NTCP in the implementation of dose escalation protocols.
    Ten Haken RK; Martel MK; Kessler ML; Hazuka MB; Lawrence TS; Robertson JM; Turrisi AT; Lichter AS
    Int J Radiat Oncol Biol Phys; 1993 Oct; 27(3):689-95. PubMed ID: 8226166
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Relationship between in vitro chromosomal radiosensitivity of peripheral blood lymphocytes and the expression of normal tissue damage following radiotherapy for breast cancer.
    Barber JB; Burrill W; Spreadborough AR; Levine E; Warren C; Kiltie AE; Roberts SA; Scott D
    Radiother Oncol; 2000 May; 55(2):179-86. PubMed ID: 10799730
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Can dose-response models predict reliable normal tissue complication probabilities in radical radiotherapy of urinary bladder cancer? The impact of alternative radiation tolerance models and parameters.
    Muren LP; Jebsen N; Gustafsson A; Dahl O
    Int J Radiat Oncol Biol Phys; 2001 Jul; 50(3):627-37. PubMed ID: 11395229
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.